CVC Technologies Inc.

TPEX:4744 Voorraadrapport

Marktkapitalisatie: NT$1.1b

CVC Technologies Inkomsten in het verleden

Verleden criteriumcontroles 2/6

CVC Technologies's earnings have been declining at an average annual rate of -20.5%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been declining at an average rate of 0.1% per year. CVC Technologies's return on equity is 4.2%, and it has net margins of 4.2%.

Belangrijke informatie

-20.5%

Groei van de winst

-22.3%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie11.5%
Inkomstengroei-0.1%
Rendement op eigen vermogen4.2%
Nettomarge4.2%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

CVC Technologies (GTSM:4744) Could Be Struggling To Allocate Capital

Apr 13
CVC Technologies (GTSM:4744) Could Be Struggling To Allocate Capital

Is CVC Technologies Inc. (GTSM:4744) A Risky Dividend Stock?

Mar 26
Is CVC Technologies Inc. (GTSM:4744) A Risky Dividend Stock?

Estimating The Fair Value Of CVC Technologies Inc. (GTSM:4744)

Mar 08
Estimating The Fair Value Of CVC Technologies Inc. (GTSM:4744)

Is CVC Technologies Inc.'s (GTSM:4744) Recent Performancer Underpinned By Weak Financials?

Feb 17
Is CVC Technologies Inc.'s (GTSM:4744) Recent Performancer Underpinned By Weak Financials?

Is CVC Technologies (GTSM:4744) A Risky Investment?

Jan 30
Is CVC Technologies (GTSM:4744) A Risky Investment?

We Like These Underlying Trends At CVC Technologies (GTSM:4744)

Jan 12
We Like These Underlying Trends At CVC Technologies (GTSM:4744)

Read This Before Buying CVC Technologies Inc. (GTSM:4744) For Its Dividend

Dec 25
Read This Before Buying CVC Technologies Inc. (GTSM:4744) For Its Dividend

Estimating The Intrinsic Value Of CVC Technologies Inc. (GTSM:4744)

Dec 07
Estimating The Intrinsic Value Of CVC Technologies Inc. (GTSM:4744)

Opbrengsten en kosten

Hoe CVC Technologies geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

TPEX:4744 Opbrengsten, kosten en inkomsten (TWD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 241,2735348948
31 Mar 241,2857246749
31 Dec 231,1271442951
30 Sep 231,026-2440849
30 Jun 23929-1237948
31 Mar 23828-935646
31 Dec 229035636344
30 Sep 229839834945
30 Jun 221,0619933846
31 Mar 221,0567333447
31 Dec 211,0957632148
30 Sep 219936931049
30 Jun 219825230149
31 Mar 211,0608929449
31 Dec 201,0286829849
30 Sep 201,0517531151
30 Jun 201,0557732852
31 Mar 201,0475533653
31 Dec 191,1229332952
30 Sep 191,1388832951
30 Jun 191,1798434051
31 Mar 191,1418034949
31 Dec 181,1698634145
30 Sep 181,0665633943
30 Jun 181,0086931140
31 Mar 181,0557931441
31 Dec 171,0133433142
30 Sep 171,1087032839
30 Jun 171,1907235138
31 Mar 171,1858634333
31 Dec 161,22614033431
30 Sep 161,26914632832
30 Jun 161,31215232234
31 Mar 161,22610031136
31 Dec 151,1414830039
30 Sep 159421629239
30 Jun 15744-1728440
31 Mar 15718-128237
31 Dec 146931528035
30 Sep 14726-327833
30 Jun 14759-2127630
31 Mar 14766-4629031
31 Dec 13773-7130431

Kwaliteitswinsten: 4744 has high quality earnings.

Groeiende winstmarge: 4744 became profitable in the past.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 4744's earnings have declined by 20.5% per year over the past 5 years.

Versnelling van de groei: 4744 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Winst versus industrie: 4744 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.5%).


Rendement op eigen vermogen

Hoge ROE: 4744's Return on Equity (4.2%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden